CD30
CD30, encoded by the TNFRSF8 gene and also known as KI-1 or D1S166E, is a member of the tumour necrosis factor receptor superfamily. It is the receptor for CD30L (TNFSF8) and signals through NF-kappa-B in activated lymphocytes. Browse Assay Genie's current range of CD30 research reagents below, or read on for the biology behind the target.
CD30 is a receptor for TNFSF8, also called CD30L. Ligand engagement regulates gene expression through activation of NF-kappa-B. The receptor is thought to play a role in the regulation of cellular growth and in the transformation of activated lymphoblasts. According to NCBI Gene, TRAF2 and TRAF5 can interact with CD30 and mediate the signal transduction that leads to NF-kappa-B activation.
The CD30 protein is a member of the TNF receptor superfamily and belongs to the TNFR8 family. UniProt records it at the cell membrane and in the cytoplasm. The receptor is expressed by activated, but not by resting, T and B cells, which makes it a marker of lymphocyte activation. The TNFRSF8 gene produces two alternatively spliced transcript variants that encode distinct isoforms. Mouse and rat both carry a Tnfrsf8 ortholog.
Functionally, CD30 is described as a positive regulator of apoptosis. It has also been shown to limit the proliferative potential of autoreactive CD8 effector T cells and to protect the body against autoimmunity. In the HGNC nomenclature the gene is listed within the CD molecules and the tumour necrosis factor receptor superfamily. Its previous symbols and names include KI-1, D1S166E and tumour necrosis factor receptor superfamily, member 8. Researchers studying lymphocyte activation, TNF receptor signalling and immune tolerance use CD30 as a reference point, whether they measure it with a CD30 antibody or a CD30 ELISA kit.
CD30 is expressed on activated but not resting T and B cells, so it is studied as a marker of lymphocyte activation state.
CD30 engages TRAF2 and TRAF5 to drive NF-kappa-B activation, making it a model for TNF receptor signal transduction.
CD30 acts as a positive regulator of apoptosis, which is relevant to studies of cell death control in activated lymphoid cells.
CD30 limits the proliferative potential of autoreactive CD8 effector T cells and helps protect against autoimmunity.
CD30 is the receptor for CD30L (TNFSF8). It activates NF-kappa-B, may regulate growth and transformation of activated lymphoblasts, and acts as a positive regulator of apoptosis. It also limits autoreactive CD8 effector T cell proliferation. Check the datasheet of any product for its validated reactivity.
The gene symbol is TNFRSF8, and the protein is named tumour necrosis factor receptor superfamily member 8. Aliases include KI-1, CD30 and D1S166E. NCBI Gene reports two alternatively spliced transcript variants that encode distinct isoforms.
Yes. Mouse and rat each have an ortholog named Tnfrsf8. The human protein belongs to the TNFR8 family within the TNF receptor superfamily. Check the datasheet of any product for its validated reactivity.
Other TNF receptor superfamily members with products at Assay Genie, useful for comparing receptor signalling and immune regulation.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P28908; product specifications from Assay Genie datasheets.